Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to find out if additional images taken during a stress echocardiogram study and risk score calculation will help the doctor determine if shortness of breath or chest pain are caused by stiff heart (heart failure with preserved ejection fraction or HFpEF).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Enrolled subjects undergoing clinical stress echocardiogram | Experimental | The enrolled subject will undergo their clinically indicated stress echocardiogram study for chest pain or shortness of breath. At the conclusion of the clinical study 4 additional echo images will be obtained for research purposes. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Echocardiogram | Diagnostic Test | Ultrasound |
|
| Measure | Description | Time Frame |
|---|---|---|
| HFpEF clinic visit at 1 month and 6 months | Number of participants undergoing resting only or exercise right heart catheterization | Within 6 months of participant enrollment |
| Confirmed HFpEF diagnosis at 1 month and 6 months | Number of participants being documented to have HFpEF diagnosis in Electronic Health Record | Within 6 months of participant enrollment |
| Estimate the prevalence of undiagnosed HFpEF in patients undergoing exercise stress echo using HFpEF probability score and exercise echo filling pressure assessment | Participants are presumed to have undiagnosed HFpEF using these following definitions:
| Within 6 months of participant enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Right heart catheterization (both resting and exercise) visit at 1 month and 6 months | Number of participants undergoing resting only or exercise right heart catheterization | Within 6 months of participant enrollment |
| SGLT2 inhibitor use at baseline, months 1 and 6 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marat Fudim, MD | Duke University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002637 | Chest Pain |
| D004417 | Dyspnea |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D004452 | Echocardiography |
| ID | Term |
|---|---|
| D057791 | Cardiac Imaging Techniques |
| D003952 | Diagnostic Imaging |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline at enrollment and 6 months post enrollment |
| MRA Use at baseline, months 1 and 6 | Baseline at enrollment and 6 months post enrollment |
| GLP1 RA use at baseline, months 1 and 6 | Baseline at enrollment and 6 months post enrollment |
| Right heart catherization (both resting and exercise) referral at months 1 and 6 | Within 6 months of participant enrollment |
| HFpEF clinical referral at months 1 and 6 | Within 6 months of participant enrollment |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D014463 | Ultrasonography |
| D006334 | Heart Function Tests |
| D003935 | Diagnostic Techniques, Cardiovascular |